| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |